 |
|
John D. Scott, Ph.D.
|
|
Dr. Scott is also Edwin G. Krebs–Hilma Speights Professor in the Department of Pharmacology at the University of Washington School of Medicine, Seattle. He received his B.Sc. (Hons) degree in biochemistry from Herriot-Watt University, Edinburgh, and his Ph.D. degree from the University of Aberdeen. He did postdoctoral research on protein kinase inhibitors in the laboratory of Edwin Krebs at the University of Washington and then joined the faculty of the University of California, Irvine before moving to the Vollum Institute at the Oregon Health & Sciences University, Portland. Dr. Scott is a fellow of the Royal Society, London, and was recently elected a fellow of the Royal Society of Edinburgh.
RESEARCH ABSTRACT SUMMARY:
John Scott is interested in the specificity of signal transduction events that are controlled by anchoring proteins, which facilitate rapid signal transduction by optimally positioning protein kinases and phosphatases in the vicinity of their activating signals and close to their substrates.
View Research Abstract
Photo: Catriona Scott
|
|
|
|
|
|
|
|
|
|
|
HHMI INVESTIGATOR
2008–
Present
University of Washington School of Medicine
1997–2008
Oregon Health & Science University
|
|
|
|
|
 |
 |
B.Sc., biochemistry, Heriot-Watt University, Edinburgh
|
|
|
Ph.D., biochemistry, University of Aberdeen
|
|
|
 |
|
The Royal Society, Fellow
|
|
|
Fellow, American Association for the Advancement of Science
|
|
|
 |
|
John Jacob Abel Award in Pharmacology, American Society for Pharmacology and Experimental Therapeutics
|
|
|
Ernst Oppenheimer Award, Endocrine Society
|
|
|
Medical Research Foundation of Oregon Discovery Award
|
|
|
MERIT Award, National Institutes of Health
|
|
|
William C. Rose Award, American Society for Biochemistry and Molecular Biology
|
|
|
D. Harold Copp Award, University of British Columbia
|
|
|
|
|
|
|
|
|
|
|
|
|
